Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists

Area of Science:

• Hepatology
• Pediatrics
• Endocrinology

Background:

• Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in children, impacting approximately 10% of this demographic.
• Central obesity and insulin resistance are primary drivers of pediatric NAFLD, with inflammation (steatohepatitis) exacerbating the condition.
• While end-stage liver disease typically manifests in adulthood, the primary morbidity and mortality in affected children stem from type 2 diabetes and atherosclerotic complications.

Purpose of the Study:

• To provide a comprehensive review of pediatric NAFLD tailored for non-specialist healthcare providers.
• To offer practical guidance and implementation strategies for managing children with NAFLD.
• To underscore the importance of early detection and management in primary care settings.

Main Methods:

• A review of current literature on pediatric NAFLD.
• Focus on etiological factors, disease progression, and diagnostic challenges.
• Emphasis on management strategies, particularly lifestyle modifications.

Main Results:

• NAFLD is a significant pediatric health concern, frequently encountered by general practitioners.
• Accurate staging of pediatric NAFLD is challenging, with liver biopsy being invasive and infrequently performed.
• Weight loss, achieved through diet and exercise, is the cornerstone of management.
• The long-term risks for affected children include type 2 diabetes and cardiovascular disease.

Conclusions:

• Pediatric NAFLD requires increased awareness and management by non-specialists.
• Effective management strategies focus on lifestyle interventions to mitigate associated metabolic risks.
• Further research is needed for non-invasive methods to assess NAFLD severity in children.